Literature DB >> 16102019

Treatment of venous thromboembolism.

H R Buller1, M Sohne, S Middeldorp.   

Abstract

This review on the treatment of patients with venous thromboembolic disease consists of three sections. The first section describes the epidemiology, natural history and reasons for treatment of venous thromboembolism (VTE), as well as a short overview on the evaluation of the use of antithrombotic agents and the spectrum of treatment options. In the second section, the evidence from clinical studies available to us in 2005 with the various treatment modalities is summarized. This section describes the current recommendations about how to treat patients with VTE initially and long term. Finally, in the third section the challenges for the treatment of patients beyond 2005 are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102019     DOI: 10.1111/j.1538-7836.2005.01414.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

Review 1.  Venous thromboembolism.

Authors:  Andrew D Blann; Gregory Y H Lip
Journal:  BMJ       Date:  2006-01-28

2.  A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants.

Authors:  Amanda J Ghanim; Constantine Daskalakis; David J Eschelman; Walter K Kraft
Journal:  J Thromb Thrombolysis       Date:  2007-03-24       Impact factor: 2.300

Review 3.  Acute pulmonary embolism. Part 2: treatment.

Authors:  Josien van Es; Renée A Douma; Victor E A Gerdes; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-09-14       Impact factor: 32.419

4.  Safety and Efficacy of Aspiration Thrombectomy or Pharmacomechanical Thrombectomy after Catheter-Directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis.

Authors:  Joong Kwon Lee; Kyung Yun Kim; Seung Jae Byun
Journal:  Vasc Specialist Int       Date:  2020-09-30

Review 5.  Rivaroxaban for the treatment of pulmonary embolism.

Authors:  Thomas Vanassche; Peter Verhamme
Journal:  Adv Ther       Date:  2013-06-27       Impact factor: 3.845

6.  Safety and efficacy of pharmacomechanical thrombolysis for acute and subacute deep vein thrombosis patients with relative contraindications.

Authors:  Xiangdong Liu; Pengkai Cao; Yunsong Li; Jianing Zhao; Liang Li; Haitao Li; Yanrong Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Evaluation of the Padua Prediction Score ability to predict venous thromboembolism in Israeli non-surgical hospitalized patients using electronic medical records.

Authors:  O Lavon; T Tamir
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

Review 8.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20

Review 9.  Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art.

Authors:  Johannes Thaler; Ingrid Pabinger; Cihan Ay
Journal:  Front Cardiovasc Med       Date:  2015-07-14

10.  Predictive value of platelet aggregation rate in postpartum deep venous thrombosis and its possible mechanism.

Authors:  Mingxia Sun; Chongdong Liu; Na Zhao; Kaikai Meng; Zhenyu Zhang
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.